Bill Lundberg

Bill Lundberg

Chief Executive Officer presso MERUS N.V.

Patrimonio netto: 7 M $ in data 29/02/2024

60 anni
Health Technology
Consumer Services
Finance

Profilo

Presently, Sven Ante Lundberg is President, CEO & Executive Director at Merus NV.
He is also on the board of Vor Biopharma, Inc., Q32 Bio, Inc. (Massachusetts) and Q32 Bio, Inc. In the past he held the position of Chief Scientific Officer of CRISPR Therapeutics AG, Medical Director for Wyeth LLC, Medical Director at Genzyme Corp., Director & Chief Medical Officer at Taligen Therapeutics, Inc., Vice President & Head-Translational Medicine at Alexion Pharmaceuticals, Inc., Principal at Antisoma Research Ltd., Vice President-Clinical Development at Sarossa Capital Ltd.
and Principal at Antisoma, Inc. Sven Ante Lundberg received a doctorate from Stanford University School of Medicine, an MBA from The Isenberg School of Management, an MBA from the University of Massachusetts and an undergraduate degree from Massachusetts Institute of Technology.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
14/04/2023 152 071 ( 0.26% ) 7 M $ 29/02/2024
26/05/2023 29 432 ( 0.04% ) 67 694 $ 29/02/2024
0.00%
25/03/2024 1 200 ( 0.00% ) 1 104 $ 29/02/2024

Posizioni attive di Bill Lundberg

SocietàPosizioneInizio
MERUS N.V. Chief Executive Officer 31/12/2019
VOR BIOPHARMA INC. Director/Board Member 31/07/2019
Director/Board Member -
Tutte le posizioni attive di Bill Lundberg

Precedenti posizioni note di Bill Lundberg

SocietàPosizioneFine
CRISPR THERAPEUTICS AG Chief Tech/Sci/R&D Officer 08/02/2018
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal 01/02/2015
Chief Tech/Sci/R&D Officer 24/02/2012
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Bill Lundberg

Formazione di Bill Lundberg

Massachusetts Institute of Technology Undergraduate Degree
University of Massachusetts Masters Business Admin
Stanford University School of Medicine Doctorate Degree
The Isenberg School of Management Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Bill Lundberg

Relazioni

100 +

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
MERUS N.V.

Health Technology

CRISPR THERAPEUTICS AG

Health Technology

VOR BIOPHARMA INC.

Health Technology

Aziende private9

Health Technology

Health Technology

Health Technology

Antisoma Research Ltd.

Health Technology

Finance

Health Technology

Health Services

Health Technology

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Bill Lundberg